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Silkworm ﬁbroin, the core of the silk ﬁlament, is an attractive
protein-polymer for biomedical applications due to its biocom-
patibility, ability to promote tissue regeneration and slow bio-
degradation. Fibroin can also be processed into a variety of 2-D
and 3-D formats to match morphological and structural features
to speciﬁc applications. Depending on the method of preparation
and the source of the silk (e.g, Bombyx mori race) with different
amino acid chemistries, the polymer can assume different struc-
tures, which lead to different mechanical and biological proper-
ties. Of particular interest in the ﬁeld of biomaterials and
associated biocompatibility is the interaction of material surfaces
with biological defense systems, such as blood coagulation and
inﬂammation. The complement interactions are mediated by a
combination of biomaterial structure and chemistry, as well as
serum protein modiﬁcations of surfaces. The focus of the pres-
ent research was to correlate the structure of the silk ﬁbroin-
derived biomaterials with plasma protein adsorption, platelet
activation and inﬂammatory cell (THP-1 cell line) adhesion and
activation.
The chemistry of the two types of silk studied inﬂuenced the
crystallinity of the ﬁlms, hydrophobicity, surface roughness and
biological interactions. Protein adsorption was lower on samples
with the higher crystallinity and hydrophobicity, mainly the che-
motactic factors (C3a, C5a, C3b), while other protein adsorption
such as ﬁbrinogen were comparable. As a consequence, platelets
and immune cells used in the present work responded to the dif-
ferent chemical and physical patterns among the various ﬁlms in
terms of their adherence, activation, and the secretion of inﬂam-
matory mediators by monocytes.
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Tissue-engineering scaffolds require chemical, structural and me-
chanical properties to provide templates that enable cells to adhere
and produce their extracellular environment. Previously, we showed
that chondrocytes prefer PLGA-scaffolds with mechanical proper-
ties similar to native cartilage, but cell-loading problems limit their
use for cartilage production in-vitro. Here we investigated chon-
drocyte growth on scaffolds produced using a natural extracellular-
matrix (ECM) protein, silkworm derived ﬁbroin as the model
biopolymer.
Scaffolds were prepared from 7% ﬁbroin/water (w/v) using
the salt leaching method and were characterized in terms of
morphology, amino acid composition, molecular weight, confor-
mation, thermal behaviour, porosity size, water absorption capa-
bility and mechanical properties. Sponges with a 500–1180 mm
pore size were used to assess chondrocyte growth. Conﬂuent cul-
tures of rat costochondral chondrocytes were released from their
native ECM by trypsin-digestion, suspended in medium, and loa-
ded onto 3mm6mm cylindrical sponges (104 cells/mm3) by
static gravity-dependent ﬁltration and by dynamic perfusion via an
orbital shaker, resulting in 87.1% and 81.8% loading efﬁciency,
respectively. Cell/scaffold constructs were cultured in DMEM
containing 10%FBS, ascorbate and antibiotics for 28-days.
At harvest, live/dead staining showed >90% cell viability re-
gardless of loading technique. Cell number, determined as a func-
tion of DNA content, increased 3.3-fold in the static-loading group
but decreased 50% for the dynamic-loading group. The chondro-
cytes on the scaffold retained their capacity to synthesis cartilage-
ECM, producing 2 mg sulfated-glycosaminoglycan/mgDNA, based
on DMMB-staining. Thus, natural silk ﬁbroin scaffolds permit ef-
ﬁcient gravity-dependent cell loading and support cell proliferation
and ECM production in-vitro, suggesting they are good alternatives
to synthetic polymeric scaffolds in-vivo.
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A tissue engineering approach combines the use of scaffold bio-
materials, stem cells and growth factors. Bone morphogenetic
proteins (BMPs) are growth factors that have sparked a great in-
terest in tissue engineering due to their strong ability to promote
new bone formation. Herein, we report the use of silk derived
nanoparticles as carriers for delivery of human BMP-2. Silks are
attractive biomaterials for tissue engineering due to its biocom-
patibility, slow biodegradability and excellent mechanical proper-
ties. Recombinant human BMP-2 was expressed in Escherichia coli
and puriﬁed by afﬁnity chromatography, showing bioactivity in
human adipose stem cells. BMP2-containing silk particles were
then prepared by a water-in-oil emulsion method. Scanning elec-
tron microscopy (SEM) revealed that silk formed nanoparticles of
100–200 nm in absence of BMP-2 and of 300–350 nmwhen BMP-2
was incorporated. Western-blot using an antibody against human
BMP-2 allowed to detect that the growth factor loaded into the
particles, and that it could be slowly released, maintaining the
original BMP-2 conformation. In human adult adipose stem cells,
the particles showed no signiﬁcant cytotoxicity and an increase in
alkaline phosphate activity. Ongoing research includes the study of
particle size by Dynamic Light Scattering (DLS), release assays
using FITC-labeled BMP-2 and FTIR analysis. Silk nanoparticles
showed to be a promising option as biomaterials for the delivery
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of bone growth factors such as BMPs for regenerative medicine
purposes.
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Integrins are transmembrane glycoproteins made of non-covalently
bonded alfa- and beta-chains. They are involved in cell-extracellular
matrix and cell-cell interaction and then in fundamental processes
such as cell adhesion, growth, and differentiation [1]. During tis-
sues development, the presence of environmental conditions per-
missive to cell differentiation is associated with the expression of
proper cell surface receptors [2]. To this regards, the possibility to
investigate cell membrane at the single molecule level is of high
potential in the ﬁeld of tissue engineering. In this work AFM probes
have been successfully functionalised and tested for the detection
of integrins expressed on the surface of a line of osteosarcoma-
derived osteoblasts named MG-63. To this purpose, monoclonal
antibodies speciﬁc to the b1 subunit of the integrins expressed by
this cell line have been covalently immobilized on the tip of sili-
con nitride AFM cantilevers by means of a bifunctional linker (PEG)
[3]. Force curves have been collected in culture medium over the
surface of both ﬁxed and living cells obtaining maps of the inter-
action between the immobilized antibodies and the respective cell
membrane receptors. The obtained results demonstrate the possi-
bility to detect speciﬁc receptors on the surface of living cells and
then the high potential of the AFM technique in the ﬁeld of tissue
engineering to investigate cell response to external environmental
conditions.
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Due to oxygen diffusion limitations, engineering of cardiac tissues
of physiologically relevant thicknesses (>1 cm) requires engineer-
ing blood vessels. Blood vessels are primarily comprised of endo-
thelial cells (ECs) and smooth muscle cells (SMCs). ECs line the
lumen whereas SMCs surround the ECs and provide vascular in-
tegrity. We and others previously demonstrated that primitive me-
sodermal progenitors derived from embryonic stem cells (ESCs)
express the receptor, Flk1, for vascular endothelial growth factor
(VEGF). When grown on collagen IV (ColIV), Flk1þ cells pref-
erentially differentiate further into ECs or SMCs in the presence or
absence of soluble VEGF-A, respectively. Previously, we demon-
strated that azidobenzoic acid-modiﬁed chitosan (Az-chitosan), a
cell-repellent cationic hydrogel, can be used to pattern cells. We
hypothesize that blood vessels can be engineered by differentiat-
ing ESCs on micropatterned ColIV with or without VEGF-A. We
immobilized VEGF-A onto negatively-charged ColIV and micro-
patterned this solution onto Az-chitosan coated coverslips. Flk1þ
ESCs differentiated in embryoid bodies for 3 days were FACS
sorted and seeded onto patterned surfaces to induce site-speciﬁc
differentiation into vascular cells. Immunostaining analyses dem-
onstrated that approximately 70% of sorted cells differentiated
into vascular cells. Using immobilized VEGF, 52 14% of cells
differentiated to ECs and 19% to SMCs. While in the absence
of immobilized or soluble VEGF, ECs and SMCs accounted
for 19 14% and 49% of the differentiated cells, respectively.
Therefore, ESCs are capable of differentiating into vascular cells
in a site-speciﬁc manner. Future work will examine the signalling
pathways of the immobilized VEGF and extend this system to 3D
structures.
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Objective: This study assessed the capacity of alginate encapsu-
lated islets to reverse diabetes in ‘‘pig to primate’’ model.
Methods: Adult pig islets were encapsulated in microcapsules
and implanted under the kidney capsula of 4 Streptozotocin-treated
primates or in subcutaneous macrodevice in 5 additional diabetic
animals. As controls, primates received non-encapsulated pig is-
lets (n¼ 2) or empty capsules (n¼ 2). Body weight, fasting blood
glucose (FBG), insulin, porcine C-peptide, HbA1C (glycosylated
haemoglobin) and anti-pig antibodies were evaluated in sera. Im-
munostaining for CD3,CD68,C3,C9 and insulin were performed
on explanted grafts.
Results: Non-encapsulated pig islets were rejected within 7 days.
Although a signiﬁcant reduction of FBG and a transient increase of
insulin/porcine C-peptide levels were observed during 2 weeks
after microencapsulated pig islets implantation, a gradual decline
of function was observed after 6 weeks. After subcutaneous trans-
plantation of a macrodevice, diabetes was corrected up to 6 months:
normal FBG (52–107mg/dl) and HbA1C (after 16 weeks) reached
8 1.4%. Two animals were retransplanted with a new macro-
device between 25 and 35 weeks after the ﬁrst graft whereas the
latter clearly dysfunctioned. Diabetes was completely controlled
again (HbA1C¼ 7.4 9.8%) ten weeks after retransplantation.
Although anti-pig IgG antibodies were evidenced in primates sera,
immunohistology demonstrated insulin positive cells inside the
graft and no sign of graft rejection. Permeability testing by lectin-
FITC revealed no permeablity to molecules over 150 KDa for al-
ginate used in macrodevice.
Conclusions: Adult pig islets encapsulated in a subcutaneous
Macrodevice can completely reverse STZ-induced diabetes up to 6
months without immunosuppression.
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